Public Company News
Jianzhi to Hold Extraordinary General Meeting On July 17, 2025
BEIJING, June 16, 2025 /PRNewswire/ -- Jianzhi Education Technology Group Company Limited (the "Company" or "Jianzhi") (NASDAQ: JZ), a leading provider of digital educational content in China, today announced it will hold an extraordinary general meeting (the "EGM") of shareholders, at its exe...
2025-06-16 20:00
1830
WuXi AppTec Recognized by Extel 2025 Asia Executive Team Rankings with Top Honors
SHANGHAI, June 16, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, has been recognized among the Top 10 "Most Honored Companies" in new rankings from Extel ...
2025-06-16 20:00
2103
Luxshare Precision Unveils 2024 Sustainability Report, Highlights Green Transition and Innovation
NEW YORK, June 16, 2025 /PRNewswire/ -- Luxshare Precision Industry Company Limited has released its 2024 Sustainability Report, detailing significant achievements in carbon reduction, clean technology innovation, and inclusive development. As a global designer and manufacturer of cable assembly ...
2025-06-16 19:37
2347
NUZ-001 Shows Promise in Zebrafish Model of Huntington's Disease
Highlights: * NUZ-001 and its active metabolite NUZ-001 Sulfone demonstrated significant neuroprotective effects in a zebrafish model of Huntington's disease * Treatment prevented hallmark developmental and morphological abnormalities, protected against neuronal cell death, restored delayed h...
2025-06-16 19:00
2267
PATHOLOGICAL COMPLETE RESPONSE RECORDED IN PATIENT FROM ACCENT CANCER TRIAL
HIGHLIGHTS * A confirmed pathological complete response has been recorded in the ACCENT trial * A pathological complete response (pCR) is extremely rare in patients undergoing treatment for advanced pancreatic cancer * A pCR means that there are no signs of cancer in tissue examined by a p...
2025-06-16 19:00
1789
Taoping Regains Compliance with Nasdaq Minimum Bid Price Requirement
SHENZHEN, China, June 16, 2025 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a provider of innovative smart cloud platform services and solutions, today announced that onJune 13, 2025, it received notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming the Company has cu...
2025-06-16 19:00
4338
Advantech Launches AFE-E420: A Revolutionary Solution for EV Charging and Energy Storage Applications
TAIPEI, June 16, 2025 /PRNewswire/ -- Advantech (TWSE: 2395), a global leader in AIoT and Edge Computing, listed in Dow Jones Sustainability World Index (DJSI-World) in 2023 and inclusion in the prestigious S&P Global 2024 Sustainability Yearbook in 2024, is thrilled to announce a new single boar...
2025-06-16 18:01
2084
Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China
SAN FRANCISCO and SUZHOU, China, June 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ...
2025-06-16 10:56
2667
Subgroup Analysis of Cadonilimab as First-Line Therapy for Advanced Cervical Cancer Reported in an Oral Presentation at ASCO 2025
HONG KONG, June 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") presented the subgroup analysis data from the Phase III COMPASSION-16 trial, evaluating cadonilimab, a first-in-class PD-1/CTLA-4 bispecific antibody, in the first-line treatment of advanced, recurrent, or ...
2025-06-16 09:25
1902
Samsung Biologics launches drug screening services, Samsung Organoids
* Samsung Organoids to provide data-driven analysis of candidate molecules * Samsung Biologics expands service scope to include preclinical research INCHEON,South Korea, June 15, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organizat...
2025-06-16 07:30
2255
Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA® (ustekinumab-stba), expanding dosing options for pediatric patients
* Approval of 45mg/0.5mL solution in a single-dose vial for subcutaneous injection expands dosing flexibility for pediatric patients with plaque psoriasis (PsO) or psoriatic arthritis (PsA) under 60kg * The FDA previously approved STEQEYMA® 45mg/0.5mL, 90mg/mL in a single-dose prefilled syrin...
2025-06-16 07:30
2092
JinkoSolar Announces Cash Dividend
SHANGRAO, China, June 13, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that its board of directors has declared a cash dividend ofUS$0.325 per ordinary...
2025-06-14 04:15
6649
VIVOTEK Earned Level 2 in TWSE's 11th Corporate Governance Evaluation, Top 5% Among NT$5-10B Cap Enterprises
MAKE TOMORROW EASIER, TODAY! AI Solutions Safeguarding a Sustainable and Safe Society TAIPEI, June 13, 2025 /PRNewswire/ -- VIVOTEK (3454-TW), the global leading security solution provider, continues to prioritize robust corporate governance. In the Taiwan Stock Exchange Corporation's Corporate...
2025-06-13 23:30
3859
TGE Pioneers an Iconic Fashion Show at the New York Stock Exchange's Trading Floor
PARIS, NEW YORK and SINGAPORE, June 13, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD" or the "Group"), alongside The Generation Essentials Group (NYSE: TGE), a subsidiary of the Group under AMTD Digital (NYSE: HKD), jointly announced that L'OFFICIEL is proud to orchestrate a groundbreaking fashion...
2025-06-13 22:06
2834
SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging
Highlights * Topline data from Clarity's diagnostic Phase II trial, SABRE, showed that 64 Cu-SAR-Bombesin was safe, well tolerated and effective at detecting prostate cancer in patients with biochemical recurrence (BCR) who are negative or equivocal on standard-of-care (SOC) scans, including pr...
2025-06-13 21:01
3598
ZKH Group Limited Announces New Share Repurchase Program
SHANGHAI, June 13, 2025 /PRNewswire/ -- ZKH Group Limited ("ZKH" or the "Company") (NYSE: ZKH), a leading maintenance, repair and operations ("MRO") procurement service platform inChina, today announced that its board of directors has authorized a new share repurchase program under which the Comp...
2025-06-13 18:00
5118
ChipMOS ADJUSTS CASH DIVIDEND DISTRIBUTION RATIO TO APPROXIMATELY NT$1.23 PER COMMON SHARE OR APPROXIMATELY US$0.82 PER ADS
HSINCHU, June 13, 2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC.
("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150
2025-06-13 18:00
4925
Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine
CHENGDU, China, June 12, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced that Prof.Jun Shi's research team from the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (Institute of Hematology, Chinese Academy of Medical Sciences) ha...
2025-06-13 17:02
1665
iQIYI celebrates fifth annual Golden Screenwriters' Night, advancing stronger industry ecosystem for screenwriting talent
BEIJING, June 13, 2025 /PRNewswire/ -- On June 11, iQIYI, China's leading online entertainment platform, hosted the annual Golden Screenwriters' Night, honoring 62 screenwriters and 20 outstanding works spanning films, drama series, and animation. Now in its fifth year, the event has become a sig...
2025-06-13 16:08
2248
XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration
CAMBRIDGE, Mass. and LIVERPOOL, United Kingdom, June 13, 2025 /PRNewswire/ -- XtalPi, a leading life sciences and new materials R&D platform powered by quantum physics, AI and robotics, today announced its acquisition of Liverpool ChiroChem (LCC), a pioneer in automated chiral chemistry technolog...
2025-06-13 15:00
5170
Week's Top Stories
Most Reposted
MTR Lab and ZGC Science City Ltd Establish Ecosystem Partnership
[Picked up by 310 media titles]
2026-03-18 12:00
HOY Unveils a Powerhouse Line-up of Talent for its Bold New Chapter
[Picked up by 301 media titles]
2026-03-20 09:36
Nature's Capital: Why Asia's Governments Are Turning to Nature-Based Solutions
[Picked up by 301 media titles]
2026-03-17 08:00Beijing InfoComm China 2026 Conference Lineup Presents Future of AI in Tech Aligning with the Nation's Next Strategic Five-Year Plan
[Picked up by 297 media titles]
2026-03-18 08:00
Agoda and Gangwon State Join Hands to Elevate Gangwon into a Premier Global Travel Destination
[Picked up by 295 media titles]
2026-03-17 11:29
Most Read
Nature's Capital: Why Asia's Governments Are Turning to Nature-Based Solutions
2026-03-17 08:00
6516
H World Group Reports Strong Full-Year 2025 Results, Driven by Asset-light Growth
2026-03-18 21:05
6262
Yunji Technology: AI Agent Revenue Soars Nearly 3x, HDOS Clients Surge 925%
2026-03-17 11:16
6188
